Global Plasma Therapy Competitive Landscape Professional Research Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	170 Pages	DIResearch	January, 2025	DIR19532306

Best Price Guarantee
Price	from $3,500
Length	170 Pages
Publisher	DIResearch
Published Date	January, 2025
SKU	DIR19532306

Global Plasma Therapy Competitive Landscape Professional Research Report 2025

Research Summary

Plasma therapy, also known as convalescent plasma therapy, is a medical treatment that involves the infusion of plasma from individuals who have recovered from a specific infection into patients currently battling the same disease. The plasma, the liquid component of blood, contains antibodies and other immune factors developed by the recovered individual to combat the infection. In the context of infectious diseases, such as viral illnesses, convalescent plasma may contain antibodies capable of neutralizing the virus. This therapy aims to boost the patient＇s immune response and assist in fighting the infection. Plasma therapy has been explored in various infectious disease outbreaks, including the treatment of severe cases of COVID-19. While it has shown promise in some instances, its effectiveness can depend on factors like the timing of administration and the specific characteristics of the disease being treated.

According to DIResearch's in-depth investigation and research, the global Plasma Therapy market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global manufacturers of Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Plasma Therapy. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Therapy market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Plasma Therapy Include:

Terumo

Arthrex

Zimmer Biomet

DePuy Synthes

EmCyte

Regen Lab

ISTO Biologics

Cesca Therapeutics

Weigao

REV-MED

Nuo Therapeutics

Plasma Therapy Product Segment Include:

Pure PRP

Leucocyte-rich PRP

Leukocyte-rich Fibrin (L-PRF)

Plasma Therapy Product Application Include:

Orthopedic

Darmatology

Cardiac Muscle Injury

Dental

Nerve Injury

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Plasma Therapy Industry PESTEL Analysis

Chapter 3: Global Plasma Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global Plasma Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global Plasma Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Plasma Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Plasma Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

1 Plasma Therapy Market Overview: 1.1 Product Definition and Statistical Scope; 1.2 Plasma Therapy Product by Type; 1.2.1 Pure PRP; 1.2.2 Leucocyte-rich PRP; 1.2.3 Leukocyte-rich Fibrin (L-PRF); 1.3 Plasma Therapy Product by Application; 1.3.1 Orthopedic; 1.3.2 Darmatology; 1.3.3 Cardiac Muscle Injury; 1.3.4 Dental; 1.3.5 Nerve Injury; 1.4 Global Plasma Therapy Market Size Analysis (2020-2032); 1.5 Plasma Therapy Market Development Status and Trends; 1.5.1 Plasma Therapy Industry Development Status Analysis; 1.5.2 Plasma Therapy Industry Development Trends Analysis
2 Plasma Therapy Market PESTEL Analysis: 2.1 Political Factors Analysis; 2.2 Economic Factors Analysis; 2.3 Social Factors Analysis; 2.4 Technological Factors Analysis; 2.5 Environmental Factors Analysis; 2.6 Legal Factors Analysis
3 Plasma Therapy Market Porter's Five Forces Analysis: 3.1 Competitive Rivalry; 3.2 Threat of New Entrants; 3.3 Bargaining Power of Suppliers; 3.4 Bargaining Power of Buyers; 3.5 Threat of Substitutes
4 Global Plasma Therapy Market Analysis by Regions: 4.1 Plasma Therapy Overall Market: 2024 VS 2025 VS 2032; 4.2 Global Plasma Therapy Revenue and Forecast Analysis (2020-2032); 4.2.1 Global Plasma Therapy Revenue and Market Share by Region (2020-2025); 4.2.2 Global Plasma Therapy Revenue Forecast by Region (2026-2032)
5 Global Plasma Therapy Market Size by Type and Application: 5.1 Global Plasma Therapy Market Size by Type (2020-2032); 5.2 Global Plasma Therapy Market Size by Application (2020-2032)
6 North America: 6.1 North America Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 6.2 North America Key Manufacturers Analysis; 6.3 North America Plasma Therapy Market Size by Type; 6.4 North America Plasma Therapy Market Size by Application; 6.5 North America Plasma Therapy Market Size by Country; 6.5.1 US; 6.5.2 Canada
7 Europe: 7.1 Europe Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 7.2 Europe Key Manufacturers Analysis; 7.3 Europe Plasma Therapy Market Size by Type; 7.4 Europe Plasma Therapy Market Size by Application; 7.5 Europe Plasma Therapy Market Size by Country; 7.5.1 Germany; 7.5.2 France; 7.5.3 United Kingdom; 7.5.4 Italy; 7.5.5 Spain; 7.5.6 Benelux
8 China: 8.1 China Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 8.2 China Key Manufacturers Analysis; 8.3 China Plasma Therapy Market Size by Type; 8.4 China Plasma Therapy Market Size by Application
9 APAC (excl. China): 9.1 APAC (excl. China) Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 9.2 APAC (excl. China) Key Manufacturers Analysis; 9.3 APAC (excl. China) Plasma Therapy Market Size by Type; 9.4 APAC (excl. China) Plasma Therapy Market Size by Application; 9.5 APAC (excl. China) Plasma Therapy Market Size by Country; 9.5.1 Japan; 9.5.2 South Korea; 9.5.3 India; 9.5.4 Australia; 9.5.5 Southeast Asia
10 Latin America: 10.1 Latin America Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 10.2 Latin America Key Manufacturers Analysis; 10.3 Latin America Plasma Therapy Market Size by Type; 10.4 Latin America Plasma Therapy Market Size by Application; 10.5 Latin America Plasma Therapy Market Size by Country; 10.5.1 Mexico; 10.5.2 Brazil
11 Middle East & Africa: 11.1 Middle East & Africa Plasma Therapy Market Size and Growth Rate Analysis (2020-2032); 11.2 Middle East & Africa Key Manufacturers Analysis; 11.3 Middle East & Africa Plasma Therapy Market Size by Type; 11.4 Middle East & Africa Plasma Therapy Market Size by Application; 11.5 Middle East & Africa Plasma Therapy Market Size by Country; 11.5.1 Saudi Arabia; 11.5.2 South Africa
12 Competition by Manufacturers: 12.1 Global Plasma Therapy Market Revenue by Key Manufacturers (2021-2025); 12.2 Plasma Therapy Competitive Landscape Analysis and Market Dynamic; 12.2.1 Plasma Therapy Competitive Landscape Analysis; 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales; 12.2.3 Market Dynamic
13 Key Companies Analysis: 13.1 Terumo; 13.1.1 Terumo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.1.2 Terumo Plasma Therapy Product Portfolio; 13.1.3 Terumo Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.2 Arthrex; 13.2.1 Arthrex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.2.2 Arthrex Plasma Therapy Product Portfolio; 13.2.3 Arthrex Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.3 Zimmer Biomet; 13.3.1 Zimmer Biomet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.3.2 Zimmer Biomet Plasma Therapy Product Portfolio; 13.3.3 Zimmer Biomet Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.4 DePuy Synthes; 13.4.1 DePuy Synthes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.4.2 DePuy Synthes Plasma Therapy Product Portfolio; 13.4.3 DePuy Synthes Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.5 EmCyte; 13.5.1 EmCyte Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.5.2 EmCyte Plasma Therapy Product Portfolio; 13.5.3 EmCyte Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.6 Regen Lab; 13.6.1 Regen Lab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.6.2 Regen Lab Plasma Therapy Product Portfolio; 13.6.3 Regen Lab Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.7 ISTO Biologics; 13.7.1 ISTO Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.7.2 ISTO Biologics Plasma Therapy Product Portfolio; 13.7.3 ISTO Biologics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.8 Cesca Therapeutics; 13.8.1 Cesca Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.8.2 Cesca Therapeutics Plasma Therapy Product Portfolio; 13.8.3 Cesca Therapeutics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.9 Weigao; 13.9.1 Weigao Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.9.2 Weigao Plasma Therapy Product Portfolio; 13.9.3 Weigao Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.10 REV-MED; 13.10.1 REV-MED Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.10.2 REV-MED Plasma Therapy Product Portfolio; 13.10.3 REV-MED Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025); 13.11 Nuo Therapeutics; 13.11.1 Nuo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information); 13.11.2 Nuo Therapeutics Plasma Therapy Product Portfolio; 13.11.3 Nuo Therapeutics Plasma Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis: 14.1 Plasma Therapy Industry Chain Analysis; 14.2 Plasma Therapy Industry Raw Material and Suppliers Analysis; 14.2.1 Plasma Therapy Key Raw Material Supply Analysis; 14.2.2 Raw Material Suppliers and Contact Information; 14.3 Plasma Therapy Typical Downstream Customers; 14.4 Plasma Therapy Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source: 16.1 Methodology/Research Approach; 16.2 Research Scope; 16.3 Benchmarks and Assumptions; 16.4 Date Source; 16.4.1 Primary Sources; 16.4.2 Secondary Sources; 16.5 Data Cross Validation; 16.6 Disclaimer